These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38226755)

  • 1. Patterns of drinking behavior around a treatment episode for alcohol use disorder: Predictions from pre-treatment measures.
    Witkiewitz K; Kirouac M; Baurley JW; McMahan CS
    Alcohol Clin Exp Res (Hoboken); 2023 Nov; 47(11):2138-2148. PubMed ID: 38226755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructs derived from the addiction cycle predict alcohol use disorder treatment outcomes and recovery 3 years following treatment.
    Witkiewitz K; Stein ER; Votaw VR; Hallgren KA; Gibson BC; Boness CL; Pearson MR; Maisto SA
    Psychol Addict Behav; 2023 May; 37(3):376-389. PubMed ID: 35951419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and measurement invariance of the Addictions Neuroclinical Assessment incentive salience domain among treatment-seekers with alcohol use disorder.
    Stein ER; Votaw VR; Swan JE; Witkiewitz K
    J Subst Abuse Treat; 2021 Mar; 122():108227. PubMed ID: 33509416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study.
    Wallach JD; Gueorguieva R; Phan H; Witkiewitz K; Wu R; O'Malley SS
    Alcohol Clin Exp Res; 2022 Jul; 46(7):1331-1339. PubMed ID: 35616436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desire thinking as a predictor of drinking status following treatment for alcohol use disorder: A prospective study.
    Martino F; Caselli G; Fiabane E; Felicetti F; Trevisani C; Menchetti M; Mezzaluna C; Sassaroli S; Albery IP; Spada MM
    Addict Behav; 2019 Aug; 95():70-76. PubMed ID: 30856546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance.
    Votaw VR; Pearson MR; Stein E; Witkiewitz K
    Alcohol Clin Exp Res; 2020 Mar; 44(3):679-688. PubMed ID: 31957027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics Associated With High-Intensity Binge Drinking in Alcohol Use Disorder.
    Gowin JL; Sloan ME; Morris JK; Schwandt ML; Diazgranados N; Ramchandani VA
    Front Psychol; 2021; 12():750395. PubMed ID: 34744927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of non-consumption outcome measures in alcohol use disorder treatment.
    Kirouac M; Witkiewitz K
    Addiction; 2019 Jun; 114(6):1086-1092. PubMed ID: 30650471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural correlates of alcohol use disorder severity among nontreatment-seeking heavy drinkers: An examination of the incentive salience and negative emotionality domains of the alcohol and addiction research domain criteria.
    Al-Khalil K; Vakamudi K; Witkiewitz K; Claus ED
    Alcohol Clin Exp Res; 2021 Jun; 45(6):1200-1214. PubMed ID: 33864389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use.
    Nieto SJ; Baskerville W; Donato S; Bujarski S; Ray L
    Am J Drug Alcohol Abuse; 2021 Sep; 47(5):630-637. PubMed ID: 34134588
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of negative emotionality, NIAAA recovery, and 3- and 6-month drinking outcomes among adults in treatment for alcohol use disorder.
    Linn BK; Zhao J; Stasiewicz PR; LaBarre C; Wilding GE; Bradizza CM
    Drug Alcohol Depend; 2023 Jan; 242():109695. PubMed ID: 36442440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Machine Learning to Classify Individuals With Alcohol Use Disorder Based on Treatment Seeking Status.
    Lee MR; Sankar V; Hammer A; Kennedy WG; Barb JJ; McQueen PG; Leggio L
    EClinicalMedicine; 2019 Jul; 12():70-78. PubMed ID: 31388665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of recovery from alcohol use disorder at three years following treatment: can the definition of recovery be extended to include high functioning heavy drinkers?
    Witkiewitz K; Wilson AD; Pearson MR; Montes KS; Kirouac M; Roos CR; Hallgren KA; Maisto SA
    Addiction; 2019 Jan; 114(1):69-80. PubMed ID: 30063267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounding Vulnerability in the Neurocircuitry of Addiction: Longitudinal Functional Connectivity Changes in Alcohol Use Disorder.
    Fede SJ; Kisner MA; Manuweera T; Kerich M; Momenan R
    Alcohol Alcohol; 2022 Nov; 57(6):712-721. PubMed ID: 35760068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implicit Alcohol Approach and Avoidance Tendencies Predict Future Drinking in Problem Drinkers.
    Martin Braunstein L; Kuerbis A; Ochsner K; Morgenstern J
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1945-52. PubMed ID: 27421061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craving and acute effects of alcohol in youths' daily lives: Associations with alcohol use disorder severity.
    Treloar H; Miranda R
    Exp Clin Psychopharmacol; 2017 Aug; 25(4):303-313. PubMed ID: 28627928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials.
    Witkiewitz K; Pearson MR; Hallgren KA; Maisto SA; Roos CR; Kirouac M; Wilson AD; Montes KS; Heather N
    Addiction; 2017 Dec; 112(12):2112-2121. PubMed ID: 28511286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Alcohol Relapse Episodes During Treatment Predict Long-Term Outcomes? Investigating the Validity of Existing Definitions of Alcohol Use Disorder Relapse.
    Maisto SA; Roos CR; Hallgren KA; Moskal D; Wilson AD; Witkiewitz K
    Alcohol Clin Exp Res; 2016 Oct; 40(10):2180-2189. PubMed ID: 27591560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.